ALS drug trial network halted early – what it means for patients
Disease control
Terminated
This study aimed to test several potential drugs for amyotrophic lateral sclerosis (ALS) in one flexible trial. It enrolled 88 adults with ALS to see if any drug could improve survival or slow disease progression. The trial was stopped early, so results are limited.
Phase: PHASE3 • Sponsor: Stichting TRICALS Foundation • Aim: Disease control
Last updated May 14, 2026 12:02 UTC